ADUS Insider Sale Notice: 9,000 Restricted Shares via Morgan Stanley

Rhea-AI Filing Summary

Addus HomeCare Corp (ADUS) submitted a Form 144 notifying a proposed sale of 9,000 common shares to be executed through Morgan Stanley Smith Barney LLC on NASDAQ approximately 08/13/2025. The filing lists an aggregate market value of $1,038,105.90 and 18,407,239 shares outstanding, implying a per-share value near $115.35 and the sale representing about 0.05% of outstanding shares.

All 9,000 shares were issued as restricted stock across grants dated 03/01/2022, 02/23/2024, 02/24/2024 and 02/24/2025. The filing reports no securities sold in the past three months and includes the seller's certification that they are not aware of undisclosed material adverse information. The document provided does not identify the individual seller or include additional issuer contact details in the visible fields.

Positive

• The filing clearly discloses the proposed sale size: 9,000 common shares and the executing broker (Morgan Stanley Smith Barney LLC), supporting market transparency.
• All shares to be sold were restricted stock granted on specific dates (2022 and 2024–2025), indicating these are dispositions of previously awarded compensation rather than new acquisitions.

Negative

• The provided content does not name the individual seller in the visible issuer/filer fields, reducing identification of the insider or affiliate.
• The filing excerpt does not state a trading plan adoption date or similar instruction date, so it is unclear whether the sale is pursuant to a pre-established Rule 10b5-1 plan based on the visible data.

Insights

Securities Analyst

TL;DR Routine insider sale notice: 9,000 restricted shares proposed for sale, immaterial relative to total outstanding shares.

The Form 144 discloses a proposed sale of 9,000 common shares with an aggregate market value of $1,038,105.90. Relative to 18,407,239 shares outstanding, the transaction equals roughly 0.05%, a de minimis reduction in share count unlikely to move markets. The shares originate from multiple restricted stock grants between 2022 and 2025, indicating this is the disposition of previously awarded compensation rather than newly purchased stock. The filing lacks the seller's name in the provided content, which limits transparency on insider level and role.

Corporate Governance Expert

TL;DR Disclosure is procedurally compliant but limited: sale is small, granted as restricted stock, and seller identity is not shown in the supplied content.

The notice follows Rule 144 form structure and names the executing broker, Morgan Stanley Smith Barney LLC. The detailed acquisition table confirms the 9,000 shares stem from restricted awards on specific dates, supporting that these are compliance-driven disclosures of insider/affiliate sales rather than open-market purchases. From a governance perspective, the absence of the seller's name and of any indicated trading plan adoption date in the visible fields reduces clarity for stakeholders assessing insider behavior, though the certification regarding material non-public information is included.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9000	1038105.90	18407239	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2024	Restricted Stock	Issuer			5325	02/24/2024	Not Applicable
Common	02/24/2025	Restricted Stock	Issuer			719	02/24/2025	Not Applicable
Common	02/23/2024	Restricted Stock	Issuer			2106	02/23/2024	Not Applicable
Common	03/01/2022	Restricted Stock	Issuer			850	03/01/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ADUS Form 144 disclose?

The Form 144 notifies a proposed sale of 9,000 common shares of Addus HomeCare (ADUS) through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $1,038,105.90.

When is the proposed sale scheduled for ADUS shares?

The filing lists the approximate date of sale as 08/13/2025.

How were the 9,000 ADUS shares acquired?

All 9,000 shares were acquired as restricted stock in grants dated 03/01/2022, 02/23/2024, 02/24/2024, and 02/24/2025.

Does the filing show any ADUS sales in the past three months?

The filing explicitly reports Nothing to Report for securities sold during the past three months.

Is the seller identified in the provided ADUS filing content?

In the content provided here, the filing does not display the name of the person for whose account the securities are to be sold.